The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex complicated chemical process. Preliminary routes focused on peptide fragment coupling, utilizing solid-phase https://mathefzoz696947.dm-blog.com/40987087/creation-and-investigation-implementations-of-retatrutide